English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

BackgroundEpidemiological profile and treatment outcomes of Lung and pleural malignancies vary among different geographical regions. The aim of the study is to analyze the clinico-pathological profile and pattern of treatment of lung and pleural cancers at the Radiation Oncology department, NCI, Cairo University.Materials and methodsA review of 804 clinical patient records with 770 pathologically/cytologically confirmed patients from Jan 2008-December 2012 was performed. Patients were evaluated (clinical, demographic and pathological profiles) in addition to the treatment adopted.ResultsMedian age was 56years with a male: female ratio of 4:1. Smoking was reported in 63% of patients. Dyspnea and chest pain were the most presenting symptoms (53%). Among lung cancer patients; 78% were NSCLC and 12% SCLC with mesothelioma comprising 10%. Among NSCLCs, adenocarcinoma and large cell undifferentiated carcinoma were the commonest histological subtype (72%). Among NSCLC, 58% cases were of stage IV while among SCLC 73% cases had extensive stage disease. Chemotherapy was administered to 47% (55% vs. 67%, and 35% vs. 31% among non-metastatic lung cancer, mesothelioma patients and metastatic lung cancer and mesothelioma patients respectively). Distant metastases (brain 48%, bone 36%) were reported in 45% of patients. The pattern of treatment intent was palliative (88%) vs. 12% treated with radical intent.ConclusionsAdvanced stages at presentation reflect the palliative pattern of treatment. Hypo-fractionated radiotherapy for lung and pleura malignancies as a palliative measure is the current practice. Implementation of early palliative care should be considered for metastatic patients

Pattern of treatment and clinico-epidemiological analysis of 804 lung and pleura cancer patients treated in radiation oncology department, NCI-Egypt